


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31198998</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1440-169X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Development, growth &amp; differentiation</Title>
                <ISOAbbreviation>Dev. Growth Differ.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>i-GONAD: A method for generating genome-edited animals without ex vivo handling of embryos.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/dgd.12620</ELocationID>
            <Abstract>
                <AbstractText>The recent development of genome editing technologies has enabled the creation of genome-edited animals, with alterations at the desired target locus. The clustered regularly interspaced short palindromic repeats (CRISPR) system is widely used for this purpose because it is simpler and more efficient than other genome editing technologies. The conventional methods for creation of genome-edited animals involve ex vivo handling of embryos (zygotes) for microinjection or in vitro electroporation. However, this process is laborious and time-consuming, and relatively large numbers of animals are used. Furthermore, these methods require specialized skills for handling embryos. In 2015, we reported a novel method for the creation of genome-edited animals without ex vivo handling of embryos. The technology known as Genome-editing via Oviductal Nucleic Acids Delivery (GONAD) involved intraoviductal instillation of genome editing components into a pregnant female and subsequent in vivo electroporation of an entire oviduct. The genome editing components present in the oviductal lumen are transferred to preimplantation embryos in situ for introducing insertion or deletion (indel) mutations at the desired loci. This technology was further improved by optimizing several parameters to develop improved GONAD (i-GONAD) for the efficient generation of mutant or knock-in animals. In this review, we discuss the historical background, potential applications, advantages, and future challenges of GONAD/i-GONAD technology.</AbstractText>
                <CopyrightInformation>© 2019 Japanese Society of Developmental Biologists.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ohtsuka</LastName>
                    <ForeName>Masato</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6952-4238</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Kanagawa, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Institute of Medical Sciences, Tokai University, Kanagawa, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sato</LastName>
                    <ForeName>Masahiro</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>15K14371</GrantID>
                    <Agency>Grant-in-Aid for challenging Exploratory Research</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>2014 Tokai University School of Medicine Research Aid</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>Research and Study Project of Tokai University General Research Organization</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>2016-2017 Tokai University School of Medicine Project Research</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2015-2019</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Dev Growth Differ</MedlineTA>
            <NlmUniqueID>0356504</NlmUniqueID>
            <ISSNLinking>0012-1592</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CRISPR</Keyword>
            <Keyword MajorTopicYN="N">gene delivery</Keyword>
            <Keyword MajorTopicYN="N">genome editing</Keyword>
            <Keyword MajorTopicYN="N">i-GONAD</Keyword>
            <Keyword MajorTopicYN="N">in vivo electroporation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31198998</ArticleId>
            <ArticleId IdType="doi">10.1111/dgd.12620</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

